Hye-Young H. Kim

Hye-Young H. Kim

Auto-generated profile, based on publicly available information

Hye-Young H. Kim

Vanderbilt University

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
Brandon LewisBrandon Lewis
Brandon Lewis
SAStephanie A Amici
Stephanie A Amici
HKHye-Young Kim
Hye-Young Kim
ESEmily M. Shalosky
Emily M. Shalosky
AKAiman Q. Khan
Aiman Q. Khan
MGMireia Guerau-De-Arellano
Mireia Guerau-De-Arellano
Severe asthma is characterized by steroid insensitivity and poor symptom control and is responsible for most asthma-related hospital costs. Therapeutic options remain limited, in part due to limited understanding of mechanisms driving severe asthma. Increased arginine methylation, catalyzed by protein arginine methyltransferases (PRMTs), is increased in human asthmatic lungs. In this study, we show that PRMT5 drives allergic airway inflammation in a mouse model reproducing multiple aspects of human severe asthma. We find that PRMT5 is required in CD4+ T cells for chronic steroid-insensitive severe lung inflammation, with selective T cell deletion of PRMT5 robustly suppressing eosinophilic and neutrophilic lung inflammation, pathology, airway remodeling, and hyperresponsiveness. Mechanistically, we observed high pulmonary sterol metabolic activity, retinoic acid-related orphan receptor γt (RORγt), and Th17 responses, with PRMT5-dependent increases in RORγt’s agonist desmosterol. Our work demonstrates that T cell PRMT5 drives severe allergic lung inflammation and has potential implications for the pathogenesis and therapeutic targeting of severe asthma.


10 January 2022 in Frontiers in Physiology
Verified
Journal Article
Open access
LZLin Zhu
Lin Zhu
JAJulia An
Julia An
SCSivaprakasam Chinnarasu
Sivaprakasam Chinnarasu
TLThao Luu
Thao Luu
YPYasminye D. Pettway
Yasminye D. Pettway
JSJohn Stafford
John Stafford
Mounting evidence has shown that CETP has important physiological roles in adapting to chronic nutrient excess, specifically, to protect against diet-induced insulin resistance. However, the underlying mechanisms for the protective roles of CETP in metabolism are not yet clear. Mice naturally lack CETP expression. We used transgenic mice with a human CETP minigene (huCETP) controlled by its natural flanking region to further understand CETP-related physiology in response to obesity. Female huCETP mice and their wild-type littermates were fed a high-fat diet for 6 months. Blood lipid profile and liver lipid metabolism were studied. Insulin sensitivity was analyzed with euglycemic-hyperinsulinemic clamp studies combined with 3H-glucose tracer techniques. While high-fat diet feeding induced obesity for huCETP mice and their wild-type littermates lacking CETP expression, insulin sensitivity was higher for female huCETP mice than for their wild-type littermates. There was no difference in insulin sensitivity for male huCETP mice vs. littermates. The increased insulin sensitivity in females was largely caused by the better insulin-mediated suppression of hepatic glucose production. In huCETP females, CETP in the circulation decreased HDL-cholesterol content and increased liver cholesterol uptake and liver cholesterol and oxysterol contents, which was associated with the upregulation of LXR target genes in long-chain polyunsaturated fatty acid biosynthesis and PPARα target genes in fatty acid β-oxidation in the liver. The upregulated fatty acid β-oxidation may account for the improved fatty liver and liver insulin action in female huCETP mice. This study provides further evidence that CETP has beneficial physiological roles in the metabolic adaptation to nutrient excess by promoting liver fatty acid oxidation and hepatic insulin sensitivity, particularly for females.

1 January 2008 in Journal of Bacteriology and Virology
Verified
Journal Article
Open access
PDF file
YGYoung-Woo Gong
Young-Woo Gong
BOBo-Young Oh
Bo-Young Oh
HKHye-Young Kim
Hye-Young Kim
MLMi Yeon Lee
Mi Yeon Lee
YKYong-Hee Kim
Yong-Hee Kim
DCDoo-Sung Cheon
Doo-Sung Cheon
Gong YW, et al. J Bacteriol Virol. 2008 Dec;38(4):249-257. http://dx.doi.org/10.4167/jbv.2008.38.4.249

1 October 2025 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
KSKevin D. Schichlein
Kevin D. Schichlein
SMSyed Masood
Syed Masood
HKHye-Young H. Kim
Hye-Young H. Kim
BHBenjamin J. Hawley
Benjamin J. Hawley
AGArunava Ghosh
Arunava Ghosh
IJIlona Jaspers
Ilona Jaspers
Vitamin D aerosols have the potential to protect against exposure to ozone and other inhaled oxidants and prevent the development and exacerbation of lung disease. Here, we show that aerosolized vitamin D treatment decreased ozone-induced oxidative stress and inflammatory responses, as well as decreased production of an oxysterol, β-epoxycholesterol, indicating vitamin D may act as a membrane antioxidant in the airway epithelium.

1 February 2025 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Open access
DDDre’vOn A. Dobson
Dre’vOn A. Dobson
APAlexia Perryman
Alexia Perryman
EMErin McNell
Erin McNell
HKHye-Young H. Kim
Hye-Young H. Kim
NPNed A. Porter
Ned A. Porter
IJIlona Jaspers
Ilona Jaspers
It is increasingly recognized that lung biology and responses to pollutant exposures differ in males and females. Using a model of differentiated nasal epithelial cells from male and female donors, our data demonstrate that pollutant-induced cytokine/chemokine responses and oxidized lipid levels vary by sex, with donor-specific oxidized lipids linked to inflammatory mediator release.